Lorenzo Emmi - Böcker

This volume aims at delivering the state-of-the-art scientific and clinical know-how for the management of patients with Connective Tissue Diseases (CTDs).

In this volume devoted to systemic lupus erythematosus (SLE) and Sjögren syndrome, leading specialists from different disciplines present the latest research findings on many aspects of the diseases and describe the most recent trends in treatment, such as the “treat to target” approach. Both basic science and clinical medicine are addressed, with emphasis on the most promising clinical and laboratory-based studies. The coverage is comprehensive in scope, encompassing, for example, epidemiology, pathogenesis, autoantibodies and biomarkers, disease manifestations, involvement of different organs or systems, relationships with other disorders, biological therapy of SLE, and systemic treatment of Sjögren syndrome. Readers will find this first volume of Connective Tissue Disease to be an excellent source of information on the current understanding of, and clinical approach to, SLE and Sjögren syndrome that clearly conveys the progress made in recent years.

In this volume devoted to systemic lupus erythematosus (SLE) and Sjögren syndrome, leading specialists from different disciplines present the latest research findings on many aspects of the diseases and describe the most recent trends in treatment, such as the “treat to target” approach.

Condizione cronica, aumentata mortalità e disabilità gravi sono i principali problemi socio-sanitari che accomunano le malattie rare del sistema immunitario, la cui bassa frequenza le rende spesso poco note ai medici, con conseguenti difficoltà e ritardi diagnostici. Una recente indagine nazionale, relativa alla totalità delle malattie rare, ha rilevato che oltre il 50 per cento dei pazienti ha ricevuto una diagnosi più di un anno dopo l’insorgere dei sintomi e che il 18 per cento ha dovuto attendere anche dieci anni.Questo volume è dedicato nello specifico alle malattie rare a patogenesi immunologica: dopo un breve inquadramento generale, le singole patologie vengono discusse attraverso interviste ai maggiori esperti di queste malattie, ai Presidenti delle associazioni e a figure professionali coinvolte nel sostegno dei pazienti. La forma del “domanda e risposta” rende questo libro una guida agile, precisa e aggiornata ai problemi reali affrontati dalle persone affette da malattie rare immuno-mediate, dalle loro famiglie e dai caregivers. Pensato quindi in primo luogo per i pazienti, questo volume è rivolto anche alle associazioni di pazienti, ai medici di medicina generale e agli esperti del settore, in cerca di informazioni su ciò che si sta facendo e su ciò che ancora resta da fare nel campo delle malattie rare e del loro impatto sulla società.

Behçet's syndrome can reasonably be considered a unique entity among diseases of the immune system for several reasons: It has specific features and, uniquely among the immune system pathologies, represents a link between autoimmune diseases, systemic vasculitis, and autoinflammatory diseases. In addition, it is of interest to a variety of specialists, including immunologists, rheumatologists, dermatologists, and ophthalmologists, and requires a complex multidisciplinary approach. Many aspects need to be considered in a syndrome that presents a wide spectrum of symptoms and for which the therapeutic armamentarium is expanding significantly, with the development of new treatments, not least the so-called biologics. This book offers comprehensive coverage of the disease by some of the world’s leading experts in Behçet's syndrome from all the relevant specialties. Epidemiology, genetics, pathogenesis, organ system involvement, differential diagnosis, novel treatments, surgical management,and prognosis are just some of the topics addressed. Behçet's Syndrome: From Pathogenesis to Treatment will be an invaluable reference for a range of practitioners, researchers, and undergraduates or postgraduates interested in immuno-rheumatology, dermatology, and rare diseases.​